Company: BDRX
Filing Date: 2025-11-17
Form Type: POS AM
Source: 0001214659-25-016826
Chunk: 15

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-17
Form: POS AM
Chunk 15
---
 we may amend or terminate the deposit agreement without your consent. If           
 you continue to hold your Depositary Shares, you agree to be bound by the terms of the deposit agreement then in effect.                         
 To better understand the terms of the Depositary Shares and the deposit                                                                          
 agreement, including applicable fees and charges, you should carefully read “Description of American Depositary Shares” in                       
 this prospectus. You should also read the deposit agreement, which is an exhibit to the registration statement that includes this prospectus..   |
| Depositary             |     | JPMorgan Chase Bank, N.A.                                                                                                                        |
| Use of proceeds        |     | We will not receive any proceeds from the sale of the Ordinary Shares represented by Depositary Shares                                           
 by the selling shareholders issuable upon exercise of the December 2023 Private Placement Pre-Funded Warrants. All net proceeds from             
 the sale of such Ordinary Shares represented by Depositary Shares will go to the selling shareholders. However, we may receive the               
 proceeds from the exercise of the December 2023 Private Placement Pre-Funded Warrants in the event the holders do not exercise the               
 warrants on a cashless basis. See the section of this prospectus titled “Use of Proceeds.”                                                       |
| Risk factors           |     | Investing in our securities involves a high degree of risk. You should read the “Risk Factors”                                                   
 section starting on page 9 of this prospectus, as well as those risk factors that are incorporated by reference in this prospectus,              
 for a discussion of factors to consider before deciding to invest in our securities.                                                             |
| Trading symbol on      
 NASDAQ for             
 Depositary Shares      |     | “BDRX”                                                                                                                                           |

| 8 |

<div align='center'>RISK FACTORS</div>

Our business has significant risks. You should consider carefully the risks set forth below and other information in this prospectus, including the information contained under the heading “Risk Factors” in our 2023 Annual Report and incorporated herein by reference, before you decide to purchase our securities. These risks and uncertainties are not the only risks and uncertainties we may face. Additional risks and uncertainties not presently known to us, or that we currently consider immaterial could also negatively affect our business, financial condition, results of operations, prospects, profits and share prices. If any of the risks described below actually occur, our business, financial condition, results of operations, prospects, profits and share prices could be materially adversely affected. See also the information contained